• 女性之声——全国妇联 2019-04-02
  • 女性之声——全国妇联 2019-03-28
  • 2018国际排联世界沙滩排球巡回赛海阳公开赛球场竣工 2019-03-28
  • 西安七旬老人拄拐到高考志愿咨询会 帮孙子看看报啥学校 2019-03-21
  • 人民日报社天津分社公开招聘工作人员公告 2019-03-21
  • 学者:“感应舍利”的出现为何是“必然” 2019-03-20
  • 卡布的专栏作者中国国家地理网 2019-03-20
  • 美国又打出2000亿关税牌,中方这300字声明暗藏玄机! 2019-03-05
  • 新余市二单位6名领导干部被纪委通报 2019-03-04
  • 图解:中国经济已现一大积极信号,你知道了吗? 2019-03-03
  • 驻工商总局纪检组问责9名司局级干部 持续发力 2019-03-03
  • 再投517亿助力湾区建设 钱江世纪城32个大项目开工 2019-02-23
  • 学习贯彻党的十九大精神 2019-02-23
  • 昆明一直升飞机在执行任务中失事 3名机组人员全部遇难 2019-02-18
  • “习近平社会治理法治思想”的核心要义及其时代价值 2019-02-17
  • Skip to main content
    Adjuvants vétérinaires prêts à l'emploi

    新疆35选7和值走势图: MONTANIDE? Range

    新疆福彩25选七 www.nwxy.net Ready-to-use veterinary adjuvants

    Selecting the right adjuvant is one of the keys to success of a veterinary vaccine in the field. Safety and efficacy balance must be taken into account, as well as the animal species and its sensitivity, the antigen (inactivated or live), its type (viral, bacterial, parasite) and its nature (crude extract, purified, recombinant, peptide, DNA), the desired immune response kinetics (short or long-term) and its profile (humoral or cellular), and the administration route (injection, mucosal, mass vaccination). Since the 70's, SEPPIC has been combining expertise and service to develop MONTANIDE? adjuvants adapted to the veterinary needs.

    MONTANIDE? range

    To meet vaccine developers' needs and to improve efficacy and stability of veterinary vaccines, SEPPIC has developed a wide range of ready-to-use adjuvants based on 3?technologies: emulsions, micro-emulsions and polymers.

    These veterinary adjuvants are manufactured under International Pharmaceutical Excipient Council (IPEC) manufacturing guidelines in SEPPIC manufacturing sites of Castres (France) and Qing Pu (China).

    MONTANIDE? safety and regulatory status

    Based on toxicological tests and field experience, MONTANIDE? adjuvants are considered as safe for veterinary applications such as vaccines.

    MONTANIDE? adjuvants and their components have been approved by the Committee for Veterinary Medical Products (CVMP) for use in immunological products. Their components are either included in the Allowed Substances table of the Annex to European Council Regulation (EU) No?37/2010 as substances needing no further Maximum Residue Limits (MRL) studies, or considered as not falling within the scope of Regulation (EC) No?470/2009 when used in a veterinary product.

    The properties of the antigenic medium are crucial for both vaccine efficacy and safety. Each team developing a vaccine has to study the safety and efficacy profile of the formula under development according to local market acceptance criteria.

    Services around MONTANIDE?

    Expertise and know how
    Bibliographic searches, vaccination protocols, efficacy screening on mice

    Formulation studies
    Selection among pharmaceutical technologies (emulsion, polymer, solid form, etc.)

    Selection of samples
    Adapted to the model of the customer for vaccine stability and performance

    Scale-up assistance
    From the laboratory to small and large scale industrial production

    Customized formulation
    For specific antigens, delivery systems, new concepts

    Training & worshops
    Vaccine formulation, laboratory and pilot processes, quality control of adjuvants and vaccines

    Regulatory affairs support
    For vaccine registration, customs, etc.

  • 女性之声——全国妇联 2019-04-02
  • 女性之声——全国妇联 2019-03-28
  • 2018国际排联世界沙滩排球巡回赛海阳公开赛球场竣工 2019-03-28
  • 西安七旬老人拄拐到高考志愿咨询会 帮孙子看看报啥学校 2019-03-21
  • 人民日报社天津分社公开招聘工作人员公告 2019-03-21
  • 学者:“感应舍利”的出现为何是“必然” 2019-03-20
  • 卡布的专栏作者中国国家地理网 2019-03-20
  • 美国又打出2000亿关税牌,中方这300字声明暗藏玄机! 2019-03-05
  • 新余市二单位6名领导干部被纪委通报 2019-03-04
  • 图解:中国经济已现一大积极信号,你知道了吗? 2019-03-03
  • 驻工商总局纪检组问责9名司局级干部 持续发力 2019-03-03
  • 再投517亿助力湾区建设 钱江世纪城32个大项目开工 2019-02-23
  • 学习贯彻党的十九大精神 2019-02-23
  • 昆明一直升飞机在执行任务中失事 3名机组人员全部遇难 2019-02-18
  • “习近平社会治理法治思想”的核心要义及其时代价值 2019-02-17